These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 7535572
1. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. Fujihara CK, De Nucci G, Zatz R. J Am Soc Nephrol; 1995 Jan; 5(7):1498-507. PubMed ID: 7535572 [Abstract] [Full Text] [Related]
3. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948 [Abstract] [Full Text] [Related]
4. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Hropot M, Langer KH, Wiemer G, Grötsch H, Linz W. Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905 [Abstract] [Full Text] [Related]
5. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. Fujihara CK, Malheiros DM, Zatz R. Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184 [Abstract] [Full Text] [Related]
6. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960 [Abstract] [Full Text] [Related]
7. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. Fujihara CK, DE Lourdes Noronha I, Malheiros DMAC, Antunes GR, DE Oliveira IB, Zatz R. J Am Soc Nephrol; 2000 Feb; 11(2):283-290. PubMed ID: 10665935 [Abstract] [Full Text] [Related]
8. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. Polichnowski AJ, Licea-Vargas H, Picken M, Long J, Bisla R, Williamson GA, Bidani AK, Griffin KA. Am J Physiol Renal Physiol; 2015 Nov 01; 309(9):F791-9. PubMed ID: 26109088 [Abstract] [Full Text] [Related]
9. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, Zatz R. Hypertension; 1996 May 01; 27(5):1165-72. PubMed ID: 8621212 [Abstract] [Full Text] [Related]
10. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Qiu C, Engels K, Baylis C. Am J Physiol; 1994 May 01; 266(5 Pt 2):R1470-6. PubMed ID: 8203622 [Abstract] [Full Text] [Related]
11. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM. Kidney Int; 1994 Aug 01; 46(2):396-404. PubMed ID: 7967351 [Abstract] [Full Text] [Related]
12. Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers. Griffin K, Polichnowski A, Licea-Vargas H, Picken M, Long J, Williamson G, Bidani A. Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F173-82. PubMed ID: 21937607 [Abstract] [Full Text] [Related]
14. A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol. Takamitsu Y, Nakanishi T, Nishihara F, Hasuike Y, Izumi M, Inoue T, Hiraoka K, Itahana R, Miyagawa K. Nephron Physiol; 2003 May 01; 93(2):p42-50. PubMed ID: 12629270 [Abstract] [Full Text] [Related]